1-5 of 5
Laure Moutouh de Parseval, MD
Close
Sort by
Journal Articles

Final Results of the Phase I Study of Lenalidomide In Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL-001 Study)

Clemens Wendtner, Peter Hillmen, MBChB, FRCP, FRCPath, PhD, Daruka Mahadevan, MD, PhD, Stephan Stilgenbauer, M.D., Lutz Uharek, Steven Coutre, Olga Frankfurt, Adrian Bloor, PhD, MRCP, FRCPath, Francesc Bosch, MD, PhD, Richard R. Furman, MD, Eva Kimby, John G. Gribben, MD, DSc, Marco Gobbi, MD, Luke Dreisbach, MD, David Duane Hurd, MD, Mikkael A. Sekeres, MD, MS, Alessandra Ferrajoli, MD, Sheetal Shah, Jennie Zhang, Laure Moutouh de Parseval, MD, Asher A. Chanan-Khan
Journal: Blood
Blood (2010) 116 (21): 1376.
https://doi.org/10.1182/blood.V116.21.1376.1376
Published: 2010
Journal Articles

Pomalidomide Modifies Sickle Cell Related Organ Damage in Transgenic Mice with Sickle Cell Anemia.

Steffen E. Meiler, MD, Marlene Wade, Laure Moutouh de Parseval, MD, Laura G Corral, Paul S. Swerdlow, MD, Ferdane Kutlar, MD, Abdullah Kutlar
Journal: Blood
Blood (2009) 114 (22): 904.
https://doi.org/10.1182/blood.V114.22.904.904
Published: 2009
Journal Articles

Lenalidomide and CC-4047 Inhibit the Proliferation of Namalwa Cancer Cells While Expanding CD34 + Progenitor Cells. New Insights on the Combination Therapy with Certain HDAC Inhibitors for Hematological Cancers.

Dominique Verhelle, PhD, Laura G. Corral, MS, Kevin Wong, BS, Jessica H. Mueller, MS, Laure Moutouh de Parseval, MD, Kristen Jensen-Pergakes, MS, Emilia Glezer, MS, Gregory D. Ferguson, PhD, Helen A. Brady, PhD
Journal: Blood
Blood (2006) 108 (11): 1120.
https://doi.org/10.1182/blood.V108.11.1120.1120
Published: 2006
Journal Articles

Lenalidomide and Novel Immunomodulatory Drugs (IMiDs®): A New Approach to the Regulation of Erythropoiesis and Hemoglobin Synthesis in Anemia.

Laure Moutouh de Parseval, MD, Helen Brady, Ph.D, Dominique Verhelle, PhD, Laura G. Corral, MS, Emilia Glezer, BS, Christopher L. Morris, MD, PhD, Roger Chen, PhD, Kyle Chan, PhD
Journal: Blood
Blood (2005) 106 (11): 2702.
https://doi.org/10.1182/blood.V106.11.2702.2702
Published: 2005
Journal Articles

Novel Immunomodulatory Drugs (IMiDs®): A Potential, New Therapy for β-Hemoglobinopathies.

Laure Moutouh de Parseval, MD., Helen Brady, PhD., Emila Glezer, MS., Normand Richard, MS., George Muller, PhD., Christopher L. Morris, MD., PhD., Dave Stirling, PhD., Kyle Chan, PhD.
Journal: Blood
Blood (2004) 104 (11): 3740.
https://doi.org/10.1182/blood.V104.11.3740.3740
Published: 2004